Atherosclerotic Cardiovascular Disease

The American Heart Association’s PREVENT equations predicted that people with stage 1 hypertension have a lower 10-year risk for atherosclerotic CVD compared with the Pooled Cohort Equations.

Ten-year atherosclerotic CVD risk for people with stage 1 hypertension was substantially lower when estimated with the new PREVENT equations vs. the Pooled Cohort Equations, researchers reported.

Patient sex had seemingly no effect on the safety and efficacy of aspirin for patients with atherosclerotic CVD, according to secondary analysis of the ADAPTABLE trial published in JAMA Cardiology.

PHILADELPHIA — A task force has issued an updated multispeciality guide to help clinicians manage diabetes, cardiorenal and metabolic diseases.

PHILADELPHIA — HDL cholesterol has not been shown to have a causal role in atherosclerotic cardiovascular disease, nor has lowering it reduced CV outcomes, but it may serve as a marker for CVD risk, according to a speaker.

PHILADELPHIA — In this Healio video exclusive, Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, presents updated multispecialty practice recommendations for diabetes, cardiorenal and metabolic diseases at the Heart in Diabetes CME Conference.

Roche announced its lipoprotein(a) assay received breakthrough device designation from the FDA to identify patients with history of atherosclerotic CVD who may benefit from Lp(a)-lowering therapy currently in development.

Disruptions in endothelial function caused by brief bouts of elicited anger may be an early predictor of heart disease, but the underlying mechanism remains unclear, researchers reported.

ATLANTA — Obicetrapib, a novel cholesteryl ester transfer protein inhibitor, reduced atherogenic lipoprotein particles alone or in combination with ezetimibe, according to new data from the ROSE2 trial.

ATLANTA — In a study of behavioral economics, researchers reported benefits of gamification and money incentives to boost daily step count for patients at high risk for CVD.